|
2025
|
Invention
|
Ackr3 modulators for cardiovascular or antiplatelet therapy. The present invention discloses a co... |
|
|
Invention
|
Tumor-specific antibody. The present invention relates to an antibody or fragment thereof specifi... |
|
2024
|
Invention
|
Antibody targeting extracellular cyclophilin a. The present invention relates to an antibody or f... |
|
|
Invention
|
Combined agents with synergistic effect against gliomas. The present invention relates to a new p... |
|
|
Invention
|
Combined agents with synergistic effects against gliomas. The present invention relates to a new ... |
|
|
Invention
|
Bioreactor, gas-exchange unit, and system from the bioreactor and the gas-exchange unit for tissu... |
|
|
Invention
|
Nucleic acid modified biological cell with expansion-dependent gene expression.
The present inve... |
|
|
Invention
|
Antibody targeting melanoma cells. The present invention relates to an antibody or fragment there... |
|
|
Invention
|
Method of predicting a patient's benefit from therapy with an immune checkpoint inhibitor. The pr... |
|
|
Invention
|
Precision immunosuppression as prevention and therapy for graft-versus-host disease. The present ... |
|
|
Invention
|
Virus-like particles with enhanced optical properties. The present invention relates to a recombi... |
|
|
Invention
|
Electroretinography system, stimulation device for an electroretinography system, method of elect... |
|
|
Invention
|
Documenting cut surfaces of histological blocks. The invention relates to a device (10; 30; 100) ... |
|
|
Invention
|
Combinations comprising an atr inhibitor with synergistic effect against gliomas. The present inv... |
|
|
Invention
|
Biocompatible structures for connecting and cultivating biological material.
The present inventi... |
|
|
Invention
|
Mhc-class i derived polypeptide. The present invention relates to a polypeptide configured to bin... |
|
|
Invention
|
Neoepitope immunogenic peptides for cancer treatment and diagnosis. The present invention relates... |
|
|
Invention
|
Glycinamide derivatives for use in the treatment of salmonellosis. The present invention relates ... |
|
|
Invention
|
2-styrylbenzothiazole derivatives as α-synuclein binding compounds. The present invention relates... |
|
|
Invention
|
Atm kinase inhibitors. The present invention discloses compounds of the general formula (Ia) or (... |
|
|
Invention
|
A cyclin-dependent kinase 2/4/9 inhibitor for the treatment of neutropenia. The invention relates... |
|
|
Invention
|
New senescence tracer generation. in vitroin vivoin vitroin vivoin vivo. |
|
|
Invention
|
Traceable chimeric antigen receptor cell. The invention relates to a composition comprising a chi... |
|
|
Invention
|
Il-15 fusion proteins with improved properties. The present invention relates to a fusion protein... |
|
|
Invention
|
Oligonucleotide encoding a tissue inhibitor of metalloproteases protein for medical use in mammal... |
|
2023
|
Invention
|
Modified immune cell. The present invention relates to an isolated immune cell, a method for prep... |
|
|
Invention
|
Peptides and combinations of peptides for use in immunotherapy against acute myeloid leukemia (am... |
|
|
Invention
|
Codon-optimized oligonucleotide for induction of elastin de-novo synthesis in mammals. The presen... |
|
|
Invention
|
Metal-binding polypeptide. The present invention relates to a polypeptide for use as a metal-bind... |
|
|
Invention
|
Compound and method for the prophylaxis and treatment of leukemia.
The invention is directed to ... |
|
|
Invention
|
Modified ace2 proteins with improved activity against sars-cov-2. The present invention relates t... |
|
|
Invention
|
Inhibitor protein of ligands of epidermal growth factor receptor (egfr). The present invention re... |
|
|
Invention
|
Peptides and combinations of peptides for use in immunotherapy against oropharyngeal squamous cel... |
|
|
Invention
|
Sars-cov-2 vaccines and uses thereof. The present disclosure relates to compositions and methods ... |
|
|
Invention
|
Nucleic acid modified biological cell with expansion-dependent gene expression. The present inven... |
|
|
Invention
|
Microfluidic device. The present invention relates to a microfluidic device, a microfluidic syste... |
|
|
Invention
|
Biocides and adhesive binding thereof. NNN'-n-tetradecyl propane-1, 3-diamine, also referred to a... |
|
|
Invention
|
Broad-spectrum antiviral agent. The present invention relates to a new broad-spectrum antiviral c... |
|
|
Invention
|
Method for making a genetic determination based on a hair root sample. The present invention rela... |
|
|
Invention
|
System and method for editing genomic dna to modulate splicing. The invention is directed to a ge... |
|
|
Invention
|
Treatment of an epilepsy-associated disorder.
The present invention relates to an apparatus for ... |
|
2022
|
Invention
|
Peptides and antigen binding proteins for use in immunotherapy against fibrolamellar hepatocellul... |
|
|
Invention
|
New compound for the treatment and prophylaxis of infectious diseases. The invention relates to a... |
|
|
Invention
|
Benzimidazole derivatives for the treatment and prophylaxis of infectious diseases. The invention... |
|
|
Invention
|
Biocompatible structures for bonding and cultivating biological material. The present invention r... |
|
|
Invention
|
Method of predicting a patient's benefit from therapy with an immune checkpoint inhibitor.
The p... |
|
|
Invention
|
Methods and compositions comprising b7-h3 binding polypetides.
The disclosure describes antibodi... |
|
|
Invention
|
Method for treating or alleviating back pain.
The present invention relates to a method for trea... |
